Yükleniyor... / Loading...
This study examines the genomic characteristics of fibrin clot structure, using blood tests, in patients with hereditary dysfibrinogenemia. It enrolled people with confirmed hereditary dysfibrinogenemia who consented to participate. It was a study with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Patient with confirmed hereditary dysfibrinogenemia * Able to give his/her informed consent to participate * Affiliated to the French Health insurance Exclusion Criteria: * Refusal to participate * pregnant and breastfeeding women, * protected adults (individuals under guardianship by court order), * adults deprived of their liberty